CVS Health Corporation $CVS Stock Position Boosted by Sumitomo Mitsui Trust Group Inc.

Sumitomo Mitsui Trust Group Inc. grew its stake in shares of CVS Health Corporation (NYSE:CVS) by 2.1% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 2,959,372 shares of the pharmacy operator’s stock after buying an additional 61,752 shares during the quarter. Sumitomo Mitsui Trust Group Inc. owned about 0.23% of CVS Health worth $223,107,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also made changes to their positions in the company. Cantor Fitzgerald Investment Advisors L.P. boosted its stake in CVS Health by 1.6% during the second quarter. Cantor Fitzgerald Investment Advisors L.P. now owns 409,735 shares of the pharmacy operator’s stock valued at $28,264,000 after buying an additional 6,615 shares in the last quarter. Alpha Omega Wealth Management LLC grew its stake in shares of CVS Health by 12.3% in the 3rd quarter. Alpha Omega Wealth Management LLC now owns 149,902 shares of the pharmacy operator’s stock worth $11,301,000 after purchasing an additional 16,418 shares during the last quarter. Aaron Wealth Advisors LLC lifted its stake in CVS Health by 177.4% during the third quarter. Aaron Wealth Advisors LLC now owns 34,259 shares of the pharmacy operator’s stock valued at $2,583,000 after purchasing an additional 21,911 shares during the last quarter. Red Mountain Financial LLC bought a new stake in CVS Health during the second quarter worth approximately $293,000. Finally, Osaic Holdings Inc. grew its position in CVS Health by 18.4% in the second quarter. Osaic Holdings Inc. now owns 229,903 shares of the pharmacy operator’s stock worth $15,828,000 after buying an additional 35,809 shares during the last quarter. Institutional investors and hedge funds own 80.66% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities analysts recently issued reports on the company. Raymond James Financial lifted their target price on CVS Health from $75.00 to $90.00 in a report on Friday, October 31st. Morgan Stanley upped their price objective on shares of CVS Health from $89.00 to $93.00 and gave the company an “overweight” rating in a research note on Wednesday, December 10th. Piper Sandler reissued an “overweight” rating and issued a $101.00 target price (up from $99.00) on shares of CVS Health in a research report on Wednesday, December 10th. The Goldman Sachs Group boosted their price target on shares of CVS Health from $93.00 to $95.00 and gave the company a “buy” rating in a report on Wednesday, December 10th. Finally, Mizuho raised their price objective on shares of CVS Health from $88.00 to $95.00 and gave the stock an “outperform” rating in a research note on Wednesday, December 10th. Two research analysts have rated the stock with a Strong Buy rating, twenty have assigned a Buy rating and four have issued a Hold rating to the stock. Based on data from MarketBeat.com, CVS Health presently has a consensus rating of “Moderate Buy” and an average price target of $94.86.

CVS Health Stock Performance

NYSE CVS opened at $80.36 on Tuesday. The firm’s 50 day simple moving average is $78.73 and its 200 day simple moving average is $74.02. The firm has a market capitalization of $102.02 billion, a price-to-earnings ratio of 211.49, a P/E/G ratio of 0.74 and a beta of 0.48. The company has a current ratio of 0.83, a quick ratio of 0.63 and a debt-to-equity ratio of 0.83. CVS Health Corporation has a 1 year low of $49.52 and a 1 year high of $85.15.

CVS Health (NYSE:CVS) last issued its quarterly earnings results on Wednesday, October 29th. The pharmacy operator reported $1.60 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.36 by $0.24. CVS Health had a return on equity of 11.45% and a net margin of 0.12%.The company had revenue of $102.87 billion for the quarter, compared to analyst estimates of $98.85 billion. During the same quarter last year, the company posted $1.09 EPS. The company’s revenue for the quarter was up 7.8% compared to the same quarter last year. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. As a group, research analysts expect that CVS Health Corporation will post 5.89 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Monday, February 2nd. Stockholders of record on Thursday, January 22nd will be issued a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a dividend yield of 3.3%. The ex-dividend date is Thursday, January 22nd. CVS Health’s payout ratio is 700.00%.

CVS Health Company Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.